| [1] | Bresson-Hadni S, Spahr L, Chappuis F. Hepatic alveolar echinococcosis[J]. Semin Liver Dis, 2021, 41(3): 393-408. | | [2] | Wang SB, Ma YB, Wang WS, et al. Status and prospect of novel treatment options toward alveolar and cystic echinococcosis[J]. Acta Trop, 2022, 226: 106252. | | [3] | Wen H, Vuitton L, Tuxun T, et al. Echinococcosis: advances in the 21st Century[J]. Clin Microbiol Rev, 2019, 32(2): e00075-18. | | [4] | Deplazes P, Rinaldi L, Alvarez Rojas CA, et al. Global distribution of alveolar and cystic echinococcosis[J]. Adv Parasitol, 2017, 95: 315-493. | | [5] | 杜云峰, 姜慧娇, 刘程豪, 等. 舒尼替尼与阿苯达唑联合用药对泡状棘球蚴治疗效果的实验研究[J]. 石河子大学学报(自然科学版), 2023, 41(5): 599-607. | | | Du YF, Jiang HQ, Liu CH, et al. Sunitinib in combination with albendazole for the treatment of alveolar echinococcosis[J]. J Shihezi Univ Nat Sci, 2023, 41(5): 599-607. (in Chinese) | | [6] | 黄燕, 喻文杰, 尚婧晔, 等. 阿苯达唑和吡喹酮交替联合用药治疗藏族牧民棘球蚴病的效果观察[J]. 中国寄生虫学与寄生虫病杂志, 2021, 39(2): 171-177. | | | Huang Y, Yu WJ, Shang JY, et al. Efficacy of alternative and combined use of albendazole plus praziquantel in the treatment of echinococcosis for Tibetan herdsmen[J]. Chin J Parasitol Parasit Dis, 2021, 39(2): 171-177. (in Chinese) | | [7] | 中国医师协会外科医师分会包虫病外科专业委员会. 肝两型包虫病诊断与治疗专家共识(2019版)[J]. 中华消化外科杂志, 2019, 18(8): 711-721. | | | The Committee of Echinococcosis Surgery, Chinese Society of Surgical Physicians, Chinese Medical Doctor Association. Expert consensus on diagnosis and treatment of hepatic cystic and alveolar echinococcosis (2019 edition)[J]. Chin J Dig Surg, 2019, 18(8): 711-721. (in Chinese) | | [8] | Craig PS, Giraudoux P, Wang ZH, et al. Echinococcosis transmission on the Tibetan Plateau[J]. Adv Parasitol, 2019, 104: 165-246. | | [9] | 四川省包虫病临床医学研究中心, 四川省医师协会包虫病专业委员会. 泡型肝包虫病诊疗专家共识(2020版)[J]. 中国普外基础与临床杂志, 2020, 27(1): 13-17. | | | Sichuan Clinical Medicine Research Center for Echinococcosis, Echinococcosis Professional Committee of Sichuan Medical Association. Expert consensus on diagnosis and treatment of alveolar echinococcosis (2020 edition)[J]. Chin J Bases Clin Gen Surg, 2020, 27(1): 13-17. (in Chinese) | | [10] | Kantarci M, Bayraktutan U, Karabulut N, et al. Alveolar echinococcosis: spectrum of findings at cross-sectional imaging[J]. Radiographics, 2012, 32(7): 2053-2070. | | [11] | Brunetti E, Kern P, Vuitton DA. Expert consensus for the diagnosis and treatment of cystic andalveolar echinococcosis in humans[J]. Acta Trop, 2010, 114(1): 1-16. | | [12] | 王茂林, 邵英梅. 肝包虫病合并门静脉海绵样变性的研究进展[J]. 临床肝胆病杂志, 2021, 37(4): 965-968. | | | Wang ML, Shao YM. Research advances in hepatic echinococcosis with cavernous transformation of the portal vein[J]. J Clin Hepatol, 2021, 37(4): 965-968. (in Chinese) | | [13] | Zawistowski M, Nowaczyk J, Jakubczyk M, et al. Outcomes of ex vivo liver resection and autotransplantation: a systematic review and meta-analysis[J]. Surgery, 2020, 168(4): 631-642. | | [14] | 李震, 丁鹏绪, 汪忠镐. 布-加综合征的规范化治疗[J]. 中国血管外科杂志(电子版), 2013, 5(3): 155-157. | | | Li Z, Ding PX, Wang ZG. Standardized treatment of Budd-Chiari syndrome[J]. Chin J Vasc Surg Electron Version, 2013, 5(3): 155-157. (in Chinese) | | [15] | Ran B, Jiang TM, Yasen A, et al. Left trisectionectomy and supra-hepatic caval reconstruction with vascular prosthesis for chronic Budd-Chiari syndrome caused by hepatic alveolar echinococcosis[J]. Chin Med J (Engl). 2019, 132(23): 2886-2888. | | [16] | Alghofaily KA, Saeedan MB, Aljohani IM, et al. Hepatic hydatid disease complications: review of imaging findings and clinical implications[J]. Abdom Radiol, 2017, 42(1): 199-210. | | [17] | 王雯, 李玮, 齐梦剑, 等. 肝细胞癌合并门静脉癌栓形成机制的研究进展[J]. 中华肝胆外科杂志, 2023, 29(4): 305-308. | | | Wang W, Li W, Qi MJ, et al. Research progress on the formation mechanism of hepatocellular carcinoma with portal vein tumor thrombus[J]. Chin J Hepatobiliary Surg, 2023, 29(4): 305-308. (in Chinese) | | [18] | 尹先敏, 种世桂, 陈根, 等. 巨噬细胞调控多房棘球蚴病所致肝纤维化研究进展[J]. 中国寄生虫学与寄生虫病杂志, 2024, 42(6): 790-795, 801. | | | Yin XM, Chong SG, Chen G, et al. Research progress of macrophage regulation of liver fibrosis induced by alveolar echinococcosis[J]. Chin J Parasitol Parasit Dis, 2024, 42(6): 790-795, 801. (in Chinese) | | [19] | 谢芝芝, 黄艳, 余新炳. 寄生虫感染致肝纤维化机制的研究进展[J]. 热带医学杂志, 2013, 13(9): 1161-1165. | | | Xie ZZ, Huang Y, Yu XB. Research progress on the mechanism of liver fibrosis caused by parasitic infection[J]. J Trop Med, 2013, 13(9): 1161-1165. (in Chinese) | | [20] | Valla DC. Budd-Chiari syndrome/hepatic venous outflow tract obstruction[J]. Hepatol Int, 2018, 12(Suppl 1): 168-180. | | [21] | Collado Aliaga J, Romero-Alegría á, Alonso-Sardón M, et al. Portal hypertension as a complication of cystic echinococcosis: a 20-Year cohort analysis[J]. Am J Trop Med Hyg, 2021, 105(3): 692-697. | | [22] | Zhang Y, Yang C, Yang H, et al. Comment on “The value of hepatic vein stent placement as a bridge therapy on treating hepatic alveolar echinococcosis presenting with Budd-Chiari syndrome”[J]. Ann Surg, 2021, 274(6): e923-e924. | | [23] | Yang C, Yang HJ, Deng SP, et al. Current status of ex-vivo liver resection and autologous liver transplantation for end-stage hepatic alveolar echinococcosis[J]. Ann Palliat Med, 2020, 9(4): 2271-2278. | | [24] | Qiu YW, Huang B, Yang XW, et al. Evaluating the benefits and risks of ex vivo liver resection and autotransplantation in treating hepatic end-stage alveolar echinococcosis[J]. Clin Infect Dis, 2022, 75(8): 1289-1296. | | [25] | Shen S, Kong JJ, Qiu YW, et al. Ex vivo liver resection and autotransplantation versus allotransplantation for end-stage hepatic alveolar echinococcosis[J]. Int J Infect Dis, 2019, 79: 87-93. | | [26] | 阿吉德, 柴金萍, 赵顺云, 等. 保留肝后下腔静脉的离体肝切除、 自体肝移植术在治疗终末期肝泡型包虫病中的临床应用[J]. 中华肝胆外科杂志, 2019, 25(11): 860-862. | | | A JD, Chai JP, Zhao SY, et al. Clinical application of isolated hepatectomy with preservation of retrohepatic inferior vena cava and autologous liver transplantation in treating end-stage alveolar hepatic hydatid disease[J]. Chin J Hepatobiliary Surg, 2019, 25(11): 860-862. (in Chinese) | | [27] | Zanetto A, Pellone M, Senzolo M. Milestones in the discovery of Budd-Chiari syndrome[J]. Liver Int, 2019, 39(7): 1180-1185. | | [28] | Mukund A, Sarin SK. Budd-Chiari syndrome: A focussed and collaborative approach[J]. Hepatol Int, 2018, 12(6): 483-486. | | [29] | Sharma A, Keshava SN, Eapen A, et al. An update on the management of Budd-Chiari syndrome[J]. Dig Dis Sci, 2021 66(6): 1780-1790. | | [30] | 徐凯, 王海久, 张丽, 等. 多房棘球蚴对宿主肝细胞损害机制的研究进展[J]. 中国寄生虫学与寄生虫病杂志, 2021, 39(2): 256-260. | | | Xu K, Wang HJ, Zhang L, et al. Research progress on the mechanisms underlying the impairment of host hepatocytes by Echinococcus multilocularis[J]. Chin J Parasitol Parasit Dis, 2021, 39(2): 256-260. (in Chinese) | | [31] | 王苗苗, 安秀青, 周鸿乾, 等. 肝多房棘球蚴病导致肝硬化的研究进展[J]. 中国人兽共患病学报, 2023, 39(11): 1130-1135. | | | Wang MM, An XQ, Zhou HQ, et al. Research progress in hepaticalveolar echinococcosis leading to cirrhosis[J]. Chin J Zoonoses, 2023, 39(11): 1130-1135. (in Chinese) | | [32] | Liu TL, Li H, Li YP, et al. Integrative analysis of RNA expression and regulatory networks in mice liver infected by Echinococcus multilocularis[J]. Front Cell Dev Biol, 2022, 10: 798551. | | [33] | Niu FQ, Chong SG, Qin MQ, et al. Mechanism of fibrosis induced by Echinococcus spp.[J]. Diseases, 2019, 7(3): 51. | | [34] | Higashi T, Friedman SL, Hoshida Y. Hepatic stellate cells as key target in liver fibrosis[J]. Adv Drug Deliv Rev, 2017, 121: 27-42. | | [35] | 玉苏甫卡迪尔·麦麦提尼加提, 艾麦提·牙森, 张瑞青, 等. 转化生长因子β1在泡状棘球蚴感染所致肝纤维化中的作用机制[J]. 医学研究生学报, 2020, 33(2): 127-132. | | | Yusufukadier MMTNJT, Aimaiti YS, Zhang RQ, et al. Role of TGF-β1 in hepatic fibrosis induced by Echinococcus multilocular infection[J]. J Med Postgrad, 2020, 33(2): 127-132. (in Chinese) | | [36] | 岳彩飞, 洪汝涛. 褪黑素对PDGF诱导肝纤维化的影响及其可能机制[J]. 重庆医科大学学报, 2021, 46(12): 1421-1424. | | | Yue CF, Hong RT. Effect of melatonin on liver fibrosis induced by platelet-derived growth factor and its possible mechanism[J]. J Chongqing Med Univ, 2021, 46(12): 1421-1424. (in Chinese) | | [37] | Sufle?el RT, Melincovici CS, Gheban BA, et al. Hepatic stellate cells-from past till present: morphology, human markers, human cell lines, behavior in normal and liver pathology[J]. Rom J Morphol Embryol, 2020, 61(3): 615-642. | | [38] | Thabut D, Routray C, Lomberk G, et al. Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis[J]. Hepatology, 2011, 54(2): 573-585. | | [39] | Bosch J, Groszmann RJ, Shah VH. Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments[J]. J Hepatol, 2015, 62(1 Suppl): S121-S130. | | [40] | DeLeve LD. Liver sinusoidal endothelial cells in hepatic fibrosis[J]. Hepatology, 2015, 61(5): 1740-1746. | | [41] | Mirzavand S, Rafiei A, Teimoori A, et al. Gene expression in human liver fibrosis associated with Echinococcus granulosus sensu lato[J]. Parasitol Res, 2020, 119(7): 2177-2187. | | [42] | 闵宏悦, 田凤鸣, 张靖仪, 等. MCP-1介导单核细胞浸润在泡型包虫病肝纤维化中的作用[J]. 中国病原生物学杂志, 2023, 18(4): 400-405, 410. | | | Min HY, Tian FM, Zhang JY, et al. Role of monocyte chemotactic protein 1-mediated monocyte infiltration in liver fibrosis of alveolar echinococcosis[J]. J Parasit Biol, 2023, 18(4): 400-405, 410. (in Chinese) | | [43] | 曹涛, 杨育文, 杨效, 等. TGF-β1 p38MAPK及BMP-7蛋白在肝多房棘球蚴病患者肝组织中的表达及意义[J]. 中国血吸虫病防治杂志, 2021, 33(4): 353-358. | | | Cao T, Yang YW, Yang X, et al. Expression and significance of TGF-β1, p38MAPK and BMP-7 protein in liver specimens of patients with alveolar hepatic echinococcosis[J]. Chin J Schisto Control, 2021, 33(4): 353-358. (in Chinese) | | [44] | Schumacher JD, Guo GL. Regulation of hepatic stellate cells and fibrogenesis by fibroblast growth factors[J]. BioMed Res Int, 2016, 2016: 8323747. | | [45] | Iwakiri Y. Nitric oxide in liver fibrosis: the role of inducible nitric oxide synthase[J]. Clin Mol Hepatol, 2015, 21(4): 319-325. | | [46] | Zhang MJ, Zhang S. T cells in fibrosis and fibrotic diseases[J]. Front Immunol, 2020, 11: 1142. | | [47] | 马福财, 杨德武, 王铮, 等. miR-106b-25基因簇在肝泡型包虫病肝组织中的表达及意义[J]. 中国人兽共患病学报, 2022, 38(7): 631-637. | | | Ma FC, Yang DW, Wang Z, et al. Expression and clinical significance of the miR-106b-25 gene cluster in liver tissues of patients with alveolar echinococcosis[J]. Chin J Zoonoses, 2022, 38(7): 631-637. (in Chinese) | | [48] | Choi JS, Jeong IS, Han JH, et al. IL-10-secreting human MSCs generated by TALEN gene editing ameliorate liver fibrosis through enhanced anti-fibrotic activity[J]. Biomater Sci, 2019, 7(3): 1078-1087. | | [49] | Tian FM, Jiang T, Qi XW, et al. Role of cytokines on the progression of liver fibrosis in mice infected with Echinococcus multilocularis[J]. Infect Drug Resist, 2021, 14: 5651-5660. | | [50] | Chen K, Kolls JK. Interluekin-17A (IL17A)[J]. Gene, 2017, 614: 8-14. | | [51] | 鄂维建, 芦永良, 祁秉民, 等. 血清巨噬细胞极化相关因子与多房棘球蚴病肝纤维化的相关性分析[J]. 临床肝胆病杂志, 2021, 37(12): 2813-2818. | | | E WJ, Lu YL, Qi BM, et al. Association between serum macrophage polarization-related factors and liver fibrosis in echinococcosis multilocularis[J]. J Clin Hepatol, 2021, 37(12): 2813-2818. (in Chinese) |
|